Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to observe the efficacy of Naltrexone and Bupropion
combination on weight loss and smoking cessation from baseline to week 24 compare to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Mental Health Center
Collaborator:
University of Massachusetts, Worcester
Treatments:
Bupropion Bupropion hydrochloride, naltrexone hydrochoride drug combination Naltrexone